Citigroup Maintains Buy on Boston Scientific, Lowers Price Target to $70

Benzinga Newsdesk www.benzinga.com Negative 73.5%

Neg 73.5% Neu 0% Pos 0%

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $87 to $70.